Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,115
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,793
Class I recallsReasonable probability of serious health consequences
24,343
Class II recallsTemporary or medically reversible health consequences
2,887
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,072 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,527 recalls have been announced year to date.
  • Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
  • The highest complete period was Jun 2026 (297).
  • Sep 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,343
Class I9,793
Class III2,887
Not Yet Classified1
Download CSV
Recalls by class
ClassRecalls
Class II24,343
Class I9,793
Class III2,887
Not Yet Classified1

Showing 7,581–7,600 of 18,020 recalls

FDA Recall Terminated Historical recordClass II

fentaNYL 200 mcg/100 mL (2 mcg/mL) ROPivacaine HCl 0.2% 200 mg/100 mL (2 mg/mL) in 0.9% Sodium Chloride , 100 mL bag, Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1108-36

by QuVa Pharma, Inc.

Reason
Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
Published
December 11, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

fentaNYL 2750 mcg/55 mL (50 mcg/mL) 55 mL Syringe, Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1100-50

by QuVa Pharma, Inc.

Reason
Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
Published
December 11, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

fentaNYL 200 mcg/100 mL (2 mcg/mL) ROPivacaine HCl 0.2% 200 mg/100 mL (2 mg/mL) in 0.9% Sodium Chloride 100 mL CADD, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478NDC 70092-1259-75

by QuVa Pharma, Inc.

Reason
Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
Published
December 11, 2019
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Regular Strength Zantac 75 mg, Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219. NDC's 67751-152-01 67751-152-02

by Sanofi-Aventis U.S. LLC

Reason
CGMP Deviations: Presence of NDMA impurity detected in product.
Published
December 11, 2019
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Regular Strength Zantac 75 mg, Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219. NDC 50269-222-25.

by Sanofi-Aventis U.S. LLC

Reason
CGMP Deviations: Presence of NDMA impurity detected in product.
Published
December 11, 2019
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Cool Mint Tablets Maximum Strength Zantac 150 mg Sanofi Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219. NDC's: 0597-0120-06, 0597-0120-08, 0597-0120-09, 0597-0120-24, 0597-0120-38, 0597-0120-50, 0597-0120-76, 0597-0120-78, 0597-0120-80, 0597-0120-82, 0597-0120-87.

by Sanofi-Aventis U.S. LLC

Reason
CGMP Deviations: Presence of NDMA impurity detected in product.
Published
December 11, 2019
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass I

Kettle Cuisine, LLC

Product
Marketside Creamy Cauliflower Parmesan Soup 16 ounce UPC C…
Reason
Soup labeled Creamy Cauliflower Parmesan Soup may contain undeclared fish and wheat
Published
December 11, 2019
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

Lamb Weston Inc

Product
Lamb Weston Grown In Idaho Crispy Hash Brown Dices, packaged…
Reason
Crispy Hash Brown Dices product is recalled because it may contain pieces of hard rubber material.
Published
December 11, 2019
Distribution
distributed in AZ, CA, CO, CT, GA, MA, M…

View recall →

FDA Recall United States Terminated Historical recordClass I

Mill Stream Corp.

Product
Sullivan Harbor Farm Smokehouse Refrigerated, Ready-to-Eat,…
Reason
Low water phase salt.
Published
December 11, 2019
Distribution
Multiple states

View recall →

FDA Recall Terminated Historical recordClass II

Potassium Phosphate, Monobasic, Crystal, NF, Multi-Compendial, Bulk Pharmaceutical Chemical, packaged in a) 500G glass bottles, product number 3248-01, NDC 10106-3248-1; b) 2.5KG glass bottles, product number 3248-05, NDC 10106-3248-2; c) 12KG pails, product number 3248-07, NDC 10106-3248-3; d) 1KT bottles and drums, product number 3248-X2; e) 1KT bottles and drums, product number 3248-X3; f) 12KG pails, product number 7390-19; Avantor Performance Materials, LLC, 100 Matsonford, Road, Suite 200, Radnor, PA 19087.

by Avantor Performance Materials Inc

Reason
Failed Stability Specifications: Product exceeds compendia and firm's specifications for iron content.
Published
December 4, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Lidocaine HCl Injection, USP, 2% 100 mg/5 mL (20 mg/mL), Preservative-Free, packaged in 10 x 5 mL Single Dose Vials per carton, Rx only, Distributed by: AuroMedics Pharma LLC, 279 Princeton-Hightstown Rd., E. Windsor, NJ 08520, NDC 55150-165-05.

by AuroMedics Pharma LLC

Reason
Presence of Foreign Substance: Foreign material found inside the vial.
Published
December 4, 2019
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Aurobindo Ranitidine Capsules 150 mg, 500 count bottle, Rx Only Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 NDC 59651-144-05

by AuroMedics Pharma LLC

Reason
CGMP Deviations: N-nitrosodimethylamine (NDMA) has been detected in Ranitidine tablets, capsules and syrups.
Published
December 4, 2019
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Ranitidine Syrup (Ranitidine Oral Solution, USP), 15 mg/mL (75 mg/5mL) 474 mL bottle, Rx only Distributed by: Aurobindo Pharma USA Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Made in India NDC 65862-431-74

by AuroMedics Pharma LLC

Reason
CGMP Deviations: N-nitrosodimethylamine (NDMA) has been detected in Ranitidine tablets, capsules and syrups.
Published
December 4, 2019
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Aurobindo Ranitidine Capsules 300 mg, 30-count bottle, Rx Only Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 NDC 59651-145-30

by AuroMedics Pharma LLC

Reason
CGMP Deviations: N-nitrosodimethylamine (NDMA) has been detected in Ranitidine tablets, capsules and syrups.
Published
December 4, 2019
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Aurobindo Ranitidine Caspules 150 mg, 60-count bottle, Rx Only Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 NDC 59651-144-60

by AuroMedics Pharma LLC

Reason
CGMP Deviations: N-nitrosodimethylamine (NDMA) has been detected in Ranitidine tablets, capsules and syrups.
Published
December 4, 2019
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

DG Health Acid Reducer Ranitidine Tablets 150 mg, 8-count carton, Distributed by: Dolgencorp LLC 100 Mission Ridge Goodletville TN 37072 NDC 55910-092-79

by AuroMedics Pharma LLC

Reason
CGMP Deviations: N-nitrosodimethylamine (NDMA) has been detected in Ranitidine tablets, capsules and syrups.
Published
December 4, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

AVKARE Ranitidine Tablets, USP 300 mg Rx Only NDC Manufactured for: AvKARE, Inc. Pulaski, TN 38478 a) 250 tablets NDC 42291-725-25; b) 30 tablets NDC 42291-725-30

by AVKARE Inc.

Reason
CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API
Published
December 4, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

AVKARE Ranitidine Tablets, USP 150 mg Rx Only Manufactured for: AvKARE, Inc. Pulaski, TN 38478 Manufactured by: Amneal Pharmaceuticals of NY Hauppauge, NY 11788 a) 1000 tablets NDC 42291-724-10; b) 180 tablets NDC 42291-724-18; c) 60 tablets NDC 42291-724-60

by AVKARE Inc.

Reason
CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API
Published
December 4, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Testosterone Cypionate 180 mg/mL/Testosterone Propionate 20mg/mL Oil Injection Solution, 10 mL per vial, New Vitalis Pharmacy

by New Vitalis Pharmacy LLC dba New Vitalis Pharmacy

Reason
Lack of sterility assurance.
Published
December 4, 2019
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Amiodarone Hydrochloride Injection, USP, 900 mg per 18 mL (50 mg / mL), 18 mL Multiple Dose Vial, Rx only, Distributed by AuroMedics Pharma LLC E. Windsor, NJ. 08520, Made in India. NDC 55150-182-18

by AuroMedics Pharma LLC

Reason
Crystallization: Presence of visible particulate matter.
Published
December 4, 2019
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.